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To determine whether myocardial contrast echocardiog 
raphy is quantitatively reproducible, repeated intracoro- 
nary injections of sonicated albumin (5%) were performed 
in eight open chest dogs. Paired injections were performed 
at baseline, during ischemia produced by ligation of a 
coronary artery, and during hyperemia induced by intra- 
venous infusion of 0.75 mg/kg body weight of dipyridamole. 
Contrast washout curves were generated for the left ante- 
rior descending coronary artery territory (ischemic area) 
and left circumflex coronary artery territory (nonischemic 
area) by beat per beat analysis of frozen end-diastolic 
frames of left ventricular short-axis views. Peak contrast 
intensity, contrast washout half-time and area under the 
curve were derived from these curves. A total of 75 contrast 
washout curves were analyzed for the study of interhtjec- 
tion, intraobserver and interobserver reproducibility. 
The correlation coefficients between measurements ob- 
tained from paired injections of the echocardiographic 
contrast agent (interinjection reproducibility) ranged from 
0.78 for peak contrast intensity to 0.87 for area under the 
curve. Percent error varied between 14.7% and 24.7%. 
The intraobserver variability in measurements was less 
than the interinjection variability, with a cumulative mean 
percent error of 17.8% and correlation coefficients of 0.72 
(peak contrast intensity), 0.95 (area under the curve) and 
0.96 (washout half-time). Interobserver correlation for all 
indexes was high (r = 0.92 to 0.96). 
It is concluded that peak contrast intensity, contrast 
washout half-time and the area under the curve derived 
from myocardial contrast washout curves can be measured 
reproducibly from videotapes. In addition, the variability 
between two injections attempted under identical condi- 
tions is greater than reader variability from videotapes. 
(J Am Co11 Cardiol1990;15:602-9) 
Myocardial perfusion imaging using contrast echocardiog- 
raphy is an exciting new technique that has been reported in 
animal studies since 1982 (1,2). It has been shown to define 
adequately the area of perfusion deficit and to correlate 
closely with the area at risk of infarction after acute coronary 
occlusion (3-8). Increasingly, myocardial contrast echocar- 
diography has been used in humans in conjunction with 
coronary arteriography (9-l 1) and coronary angioplasty 
(12-14) as a means of noninvasively defining myocardial 
perfusion and coronary blood flow reserve (15-17). 
Although myocardial contrast echocardiography shows 
great promise for evaluating patients with coronary artery 
disease, it has intrinsic limitations. Factors such as the use of 
hyperosmolar, biologically active solutions, which may alter 
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autoregulation of the vasculature, the administration of 
nonstandardized manual intracoronary injections of contrast 
agents, the timing of injection during the cardiac cycle, the 
absolute size, volume and concentration of microbubbles 
injected, as well as gain settings and methods of analysis 
(18) may cause significant variability in myocardial contrast 
echocardiographic measurements. With respect to these 
limitations, it is important to determine whether measure- 
ments derived from myocardial contrast echocardiography 
are reproducible if this technique is to be used to quantitate 
myocardial blood flow. 
Accordingly, the present study was undertaken to test the 
variability of measurements derived from videodensitomet- 
ric analysis of time-intensity curves generated after injection 
of an ultrasound contrast agent by assessing interinjection, 
intraobserver and interobserver reproducibility. 
Methods 
Surgical preparation and instrumentation. This study 
conformed to the position of the American Heart Associa- 
tion on research animal use. Eight mongrel dogs weighing 20 
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to 25 kg were anesthetized with intravenous sodium pento- 
barbital (30 mg/kg body weight), intubated and ventilated 
with a Harvard respirator. The sodium pentobarbital was 
administered as needed for maintenance of anesthesia. A 7F 
catheter, placed into the descending aorta by way of the right 
femoral artery, was used for systemic pressure monitoring, 
and a 7F Swan-Ganz catheter was inserted into the femoral 
vein and positioned in the pulmonary artery. The dogs were 
then placed in the right lateral decubitus position and their 
chest opened by left lateral thoracotomy through the fourth 
intercostal space. The pericardium was incised and used as a 
cradle for the exposed heart. Large diagonal branches of the 
left anterior descending coronary artery were dissected and 
suture material was placed around them for eventual liga- 
tion. After prophylactic administration of intravenous 
lidocaine (2 mg/kg), a 22-gauge catheter was inserted into a 
diagonal branch proximal to the suture and advanced retro- 
grade into the left main coronary artery for selective intra- 
coronary injections of echocardiographic contrast medium. 
Echocardiographic contrast agent preparation. A model 
W-375 sonicator (Heat Systems-Ultrasonics) with a 0.5 in. 
(1.27 1 n) diameter horn was used to generate microbubbles. 
Ten n lliliters of 5% human albumin (American Red Cross) 
was sonicated for 75 s by a method of sonication previously 
described (19). This method produced a stable echocardio- 
graphic contrast agent containing microbubbles of 5.2 ? 2.6 
pm in diameter by Coulter counter. 
Echocardiographic examination. The dogs were placed in 
the right lateral decubitus position on a specially built table 
with a central opening. Closed chest two-dimensional echo- 
cardiographic images were obtained with a Toshiba SSH-40 
instrument. A 5 MHz transducer held by a clamp was 
positioned below the closed right hemithorax at the point of 
maximal cardiac impulse. The transducer was positioned to 
continuously image the left ventricle in a short-axis view at 
the midpapillary muscle level; this position and angle were 
maintained throughout the study. The gain settings were 
adjusted at the beginning of each study and kept unchanged 
throughout the study. All echocardiographic images were 
recorded on videotape for subsequent analysis, beginning 
before injection and continuing until complete disappearance 
of contrast. 
Experimental protocol. Baseline echocardiograms were 
recorded after completion of the surgical preparation. Re- 
peat manually administered intracoronary injections of 2 ml 
of the echocardiographic contrast agent were then carried 
out in three different states: at baseline, 20 min after ligation 
of one large or two or three smaller diagonal coronary artery 
branches and 10 min after intravenous administration of 
dipyridamole, 0.75 mglkg body weight. For each state (base- 
line, occlusion and occlusion plus dipyridamole), paired 
intracoronary injections of contrast medium were performed 
at 5 min intervals by the same investigator. During dipyri- 
damole-induced hyperemia. arterial blood pressure and pul- 
monary capillary wedge pressure were maintained at base- 
line levels with fluids and, if necessary with infusion of 
phenylephrine hydrochloride (20 mg in 500 ml of 5% dex- 
trose in water). 
Echocardiographic data analysis. Videotapes were ana- 
lyzed off-line using a commercially available MicroSonics 
DataVue system. Echocardiographic frames were operator 
selected by freezing the desired image at end-diastole syn- 
chronized to the peak of the R wave on the electrocardio- 
gram. In addition, each frame was aligned with the baseline 
frame using a tracing of the endocardial borders as a refer- 
ence. Two large areas of interest (1,000 to 2,000 pixels each) 
were traced by the operator in the territory of the left 
anterior descending coronary artery (ischemic area) and left 
circumflex coronary artery (nonischemic area) (Fig. 1). The 
endocardial and epicardial borders and papillary muscles 
were excluded from the tracing. The position and size of the 
region of interest were kept constant throughout the analysis 
of each injection. Contrast intensity was quantitated by 
videodensitometry using a software package for videoden- 
sity analysis based on a level of 256 units of gray scale. 
Videodensitometric analysis of myocardial contrast was 
carried out within the area of interest using computer- 
generated, time-intensity curves. Measurements were done 
in the ischemic area at baseline (before occlusion), after 
occlusion, after dipyridamole and in the nonischemic area at 
baseline and after dipyridamole in order to generate data 
over a wide range of flow rates. The preinjection baseline 
intensity was subtracted from all points in the time-activity 
curves, yielding three indexes of myocardial perfusion: peak 
contrast intensity, half-time of contrast washout and area 
under the curve of ultrasound contrast intensity versus time. 
Washout half-time (TYz) was calculated from the decay 
phase of the curve using a least squares fit by the equation 
TM = In 2/k (where In = natural logarithm and k = 
exponential decay rate) (20). The area under the decay 
portion of the time-intensity curve was calculated by the 
equation Area = T% x Peak contrast intensity/in 2. 
Reproducibility analysis. To study the interinjection re- 
producibility of peak contrast intensity, washout half-time 
and area under the curve measurements, we compared the 
results generated from analysis of paired injections per- 
formed at 5 min intervals during each flow state. For the 
assessment of interobserver and intraobserver reproducibil- 
ity, a subset of 17 contrast injections, selected at random, 
were quantitated by an independent observer and at a 
different time by the initial observer. 
Statistical analysis. Interinjection, intraobserver and in- 
terobserver variability for peak videointensity, washout half- 
time and area under the curve are each expressed as percent 
error, calculated by taking the difference between two 
measurements of one variable and expressing it as a percent 
of the initial measurement (21). A paired t test was used to 
compare mean values. Linear regression analysis was used 
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Figure 1. End-diastolic frames of two-dimensional echocardio- 
grams of the left ventricle in short-axis view acquired before (a) and 
after (b) intracoronary injection of the contrast agent. a) Outlines of 
the epicardial and endocardial borders are shown (white arrows). 
b) Areas of interest (black arrows) in the perfusion territory of the 
left anterior descending coronary artery (LAD, ischemic area) and 
left circumflex coronary artery (Cx, nonischemic area) are shown. 
for correlation between measurements from the first and 
second study. Individual components of variance were as- 
sessed by analysis of variance for repeated measurements. 
All values are presented as mean values + 1 SD, and 
statistical significance is defined as p < 0.05. 
Table 1. Interinjection Reproducibility In Six Dogs 
First Second Absolute 
Injection Injection Error % Error r Value 
VD 45.2 + 11.9 41.9 + 12.0 6.6 ? 5.6 14.7 * 11.1 0.78 
TM 9.6 t 5.1 9.0 ? 5.2 2.1 * 2.5 19.3 2 15.7 0.81 
Area 591 ? 322 576 r 351 132 + 111 24.7 2 15.7 0.87 
*Values are expressed as mean values 2 SD. Area = area under the curve 
in arbitrary units; TYz = contrast washout half-time in cardiac cycles; VD = 
peak videointensity in gray scale units/pixel. 
Results 
Animal results. The experimental protocol was unsuc- 
cessful in one dog because of technical problems with the 
intracoronary cannula. Another dog was excluded from the 
analysis because of high preinjection intensity values and an 
associated problem of machine-generated nonlinearity of the 
signal at higher intensity levels. A total of 75 time-intensity 
curves were analyzed in the remaining six dogs. 
Interinjection reproducibility. The results of the interin- 
jection reproducibility study for peak videointensity, wash- 
out half-time and area under the curve are presented in Table 
1 and Figure 2. The mean values for the paired measure- 
ments were not significantly different, mean percent error 
varying between 14.7% (peak contrast intensity) and 24.7% 
(area under the curve). A good correlation was found be- 
tween measurements derived from two sequential injections 
(r = 0.78 to 0.87) with area under the curve being the most 
reproducible variable (r = 0.87). 
Intraobserver reproducibility. Measurements from a first 
and second reading are presented in Table 2; mean percent 
error varied between 11.8% and 22.7%. Figure 3 shows the 
scatter diagram and r values. Reproducibility was higher 
than that for two injections. The best correlation coefficient 
was found for washout half-time and area under the curve 
(r = 0.96 and r = 0.95, respectively), whereas peak contrast 
intensity had the poorest correlation (r = 0.72). 
Interobserver reproducibility. Table 3 shows the mean 
values and variability for the three variables tested. Cumu- 
lative mean percent error was 19.1% (range 7.9% to 27%). 
Figure 4 presents the individual measurements and r values. 
Interobserver correlation for all indexes was high (r > 0.9). 
Components of variance. Variability between measure- 
ments varied greatly from dog to dog. This “dog factor” was 
the largest component of variance for all indexes (p < 0.001). 
Variability was greater after dipyridamole (p = 0.01 for 
videointensity; p < 0.001 for washout half-time and area 
under the curve). The order of injection or measurement 
(first versus second) was not a significant factor. 
Discussion 
The potential of myocardial contrast echocardiography to 
assess myocardial blood flow has been shown in animal and 
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Figure 2. Interinjection variability in contrast echocardiographic 
measurements of peak videodensity (A), contrast washout half-time 
(B) and area under the curve (C). The r value was obtained from 
linear regression analysis. The dashed line is the line of identity. 
human studies. Peak videointensity, contrast washout half- 
time and area under the curve, derived from time-intensity 
curves generated after injection of the ultrasound contrast, 
are commonly evaluated variables of the myocardial con- 
trast effect and show promise for the actual quantitation of 
myocardial blood flow (22). However, the goal of quantifi- 
cation of absolute myocardial blood flow has yet to be 
achieved. Many theoretical and practical problems remain in 
Table 2. Intraobserver Reproducibility In Six Dogs 
First Second Absolute 
Reading Reading Error % Error r Value 
VD 47.9 k 10.0 43.6 ” 10.2* 6.0 + 6.2 11.8 + 11.2 0.72 
TV2 9.1 2 6.4 10.4 + 7.8 2.1 f 2.2 22.7 + 20.0 0.96 
Area 640 + 403 690 2 513 131 2 130 19.0 + 14.1 0.95 
*p < 0.05 versus measurements from the first reading. Values are 
expressed as mean values 5 SD. Abbreviations as in Table 1. 
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the quantitative analysis of myocardial perfusion by video- 
densitometry, and the reproducibility of any quantitative 
measure must be defined before the technique can be applied 
to clinical practice. 
Interinjection variability. Our results indicate that a re- 
peat injection introduced the largest component of variance. 
The amount of variability differed among the dogs and was 
greater at higher flow levels. The order of injection (first 
versus second) did not significantly account for the interin- 
jection variability observed. This latter finding can be ex- 
pected with the use of sonicated contrast agents with small 
microbubble size capable of crossing the capillary bed 
without causing plugging of the microcirculation and persist- 
ent contrast effect. 
Several factors may contribute to this interinjection vari- 
ability, including biological factors, differences in sonication 
technique, absolute size and concentration of microbubbles 
in individual injections, nonstandardized manual intracoro- 
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nary injections of contrast agents, and quality and stability of 
echocardiographic images during each experiment. Although 
no significant change in hemodynamic status was observed 
during the paired injections, it is possible that small hemo- 
dynamic differences may have accounted for some of the 
variability observed. 
By application of sonication techniques, microbubbles of 
smaller, more uniform size have been produced (23). In this 
Table 3. Interobserver Reproducibility In Six Dogs 
First Second Absolute 
Observer Observer Error % Error r Value 
VD 49.4 r 8.3 50.0 * 10.7 3.8 + 2.2 7.9 k 5.8 0.92 
TV2 9.5 + 6.3 11.4 * 7.8 2.0 + 2.1 22.4 ? 21.1 0.96 
Area 676 f 387 836 ? 519* 174 + 194 27.0 + 23.8 0.94 
*p < 0.05 versus measurements by the first observer. Values are ex- 
pressed as mean values + SD. Abbreviations as in Table 1. 
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Figure 3. Intraobserver variability in contrast echocardiographic 
measurements of peak videodensity (A), contrast washout half-time 
(B) and area under the curve (C). The r value was obtained from 
linear regression analysis. The dashed line is the line of identity. 
study, we used sonicated albumin, a new echocardiographic 
contrast agent, that has been proposed as a nearly ideal echo 
contrast agent with little myocardial toxicity or hemody- 
namic effect (24). Keller et al. (25) reported the improved 
characteristics of this agent in animals. However, despite 
modern sonication techniques, variability in absolute mi- 
crobubble concentration may still occur with each sonica- 
tion. The absolute size and number of microbubbles are 
significant factors in determining the overall intensity of 
contrast effect (26). This problem may be partially overcome 
with the development of commercial agents having known 
microbubble size and concentration, such as Albunex (Mo- 
lecular Biosystems, Inc.) (27). 
Rigid standardization of the injectant and intracoronary 
injection technique, by the use of electrocardiographic-gated 
volume and pressure-controlled injectors, could reduce the 
effects of the injection process on the native blood flow 
patterns within the myocardial tissue (28). However, this 
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Figure 4. Interobserver variability in contrast echocardiographic 
measurements of peak videodensity (A), contrast washout half-time 
(B) and area under the curve (C). The r value was obtained from 
linear regression analysis. The dashed line is the line of identity. 
application may be limited in clinical studies, as mechanical 
intracoronary injections are probably more hazardous than 
Reader variability. The means of analyzing contrast 
echocardiograms has varied among laboratories. Commer- 
hand injections. 
cially available ultrasonic equipment and tedious off-line 
methods of frame grabbing and videodensitometric analysis 
have been used by most investigators. Limitations of the 
currently used methods may be overcome by new develop- 
ments in ultrasound systems with on-line, digital acquisition 
and more convenient computer algorithms for plotting time- 
intensity curves (29-32). We found that the reproducibility 
among repeated measurements by one reader (intraobserver 
reproducibility) and different readers (interobserver repro- 
ducibility) was high. Our results suggest that these new 
developments may have less impact on improving the quan- 
titative analysis of myocardial contrast echocardiography 
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than on the development of echocardiographic contrast 
agents and injection methods associated with superior repro- 
By design, our study minimized or excluded several other 
factors that would increase variability, such as performance 
ducibility. 
of sonication or serial injections by different observers, use 
of different ultrasonographic systems for the recording of 
contrast echocardiograms and differences in measurement 
definition. In clinical studies, changes in transducer location 
and patient position between serial injections may further 
increase this variability. 
Peak contrast intensity was the least reproducible of the 
three variables derived from the contrast time-intensity 
curves (cumulative r values of 0.81, 0.91 and 0.92 for peak 
intensity, washout half-time and area under the curve, 
respectively). Our findings may help explain the conflicting 
results among various studies that have correlated peak 
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contrast intensity with flow (33,34), for example, the sugges- 
tion of Keller et al. (17) that area under the time-intensity 
curve is best related to coronary blood flow. In our study, 
area under the curve was the most reproducible variable, 
suggesting that it may be the most useful variable for the 
study of myocardial perfusion. 
Although we have not specifically studied the confidence 
limits of individual variables, we have observed wide inter- 
subject variability. This finding suggests that if myocardial 
contrast echocardiography is to be used to quantitate myo- 
cardial blood flow, changes in individual subjects’ values, 
rather than in absolute values, have a greater chance of being 
useful. 
Conclusions. Variables derived from myocardial contrast 
washout curves, such as peak contrast intensity, contrast 
washout half-time and area under the curve, are reproduc- 
ible at different coronary blood flow levels. However, sig- 
nificant variability exists between paired injections per- 
formed during controlled conditions, probably indicating 
slightly different sonication results and injection technique, 
whereas measurements obtained by repeated readings of one 
reader (intraobserver) and between two readers (interob- 
server) were found to be highly reproducible. Contrast 
washout half-time and area under the curve variables were 
more reproducible than peak contrast intensity. Search for 
ways to enhance the reproducibility of myocardial contrast 
echocardiography should continue if this technique is to be 
used to quantitate myocardial blood flow. 
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technical assistance, Sungsub Choi for statistical advice, Patricia A. Faiello 
for secretarial assistance and Thomas E. J. Gayeski for manuscript review and 
helpful suggestions. 
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